Sean Wirtjes Sells 6,027 Shares of Rapid Micro Biosystems (NASDAQ:RPID) Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CFO Sean Wirtjes sold 6,027 shares of Rapid Micro Biosystems stock in a transaction on Monday, February 9th. The stock was sold at an average price of $3.78, for a total value of $22,782.06. Following the completion of the transaction, the chief financial officer owned 483,928 shares in the company, valued at $1,829,247.84. The trade was a 1.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Rapid Micro Biosystems Trading Up 2.9%

NASDAQ:RPID opened at $4.20 on Thursday. The stock has a fifty day simple moving average of $3.67 and a 200 day simple moving average of $3.40. The firm has a market capitalization of $186.14 million, a price-to-earnings ratio of -4.16 and a beta of 1.38. Rapid Micro Biosystems, Inc. has a 1-year low of $1.86 and a 1-year high of $4.94. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in RPID. Hudson Bay Capital Management LP purchased a new stake in Rapid Micro Biosystems in the 3rd quarter worth approximately $38,000. American Century Companies Inc. increased its stake in shares of Rapid Micro Biosystems by 46.1% in the second quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock worth $58,000 after acquiring an additional 5,341 shares during the last quarter. Nano Cap New Millennium Growth Fund L P acquired a new position in shares of Rapid Micro Biosystems in the fourth quarter worth $72,000. XTX Topco Ltd purchased a new stake in shares of Rapid Micro Biosystems during the second quarter worth $144,000. Finally, Goldman Sachs Group Inc. acquired a new stake in Rapid Micro Biosystems during the fourth quarter valued at $160,000. Institutional investors and hedge funds own 52.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, January 22nd. Wall Street Zen downgraded shares of Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a research note on Saturday, January 17th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Rapid Micro Biosystems presently has a consensus rating of “Hold” and a consensus price target of $8.00.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.